Related Experiment Video
Updated: May 14, 2026

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
Published on: September 16, 2020
[Effect of resveratrol on the fundus oculi. An overview]
1Universitäts-Augenklinik Münster, Albert-Schweitzer-Campus 1, Gebäude D15, 48149 Münster. anne.alex@ukmuenster.de
Abstract:
Resveratrol is a polyphenol with various properties. Oncological studies have shown an excellent anti-carcinogenic effect. Due to many overlaps between tumor-mediating signaling pathways and those which mediate neovascularization and proliferation in retinal diseases, this review intends to focus on studies about the application of resveratrol in diseases of the eye fundus in vitro and in vivo. Resveratrol has been well investigated in cell culture studies and animal models. Ophthalmological in vitro and in vivo investigations have shown a large variety of possible effects without toxic side effects and antiproliferative and immune modulatory effects in particular were observed. There is general consensus that the target protein of resveratrol is NF-κB. Clinical studies are needed to confirm these effects observed in cell culture and animal models. The exact mechanism of resveratrol remains unknown and seems to vary between cell types, tissues and the pathophysiological environment.
Insights
Resveratrol, a polyphenol, shows promise for treating eye fundus diseases by inhibiting cell proliferation and modulating immune responses. Further clinical studies are needed to confirm its therapeutic potential and understand its exact mechanisms.
Area of Science:
- Ophthalmology
- Pharmacology
- Molecular Biology
Background:
- Resveratrol, a natural polyphenol, exhibits significant anti-carcinogenic properties.
- Tumor signaling pathways share similarities with those involved in retinal diseases, suggesting potential therapeutic applications for resveratrol.
- Previous research has explored resveratrol's effects in various cell culture and animal models.
Purpose of the Study:
- To review existing in vitro and in vivo studies on the application of resveratrol in eye fundus diseases.
- To investigate the antiproliferative and immune modulatory effects of resveratrol in ophthalmological contexts.
- To explore the potential of resveratrol as a therapeutic agent for retinal conditions.
Main Methods:
- Comprehensive literature review of in vitro and in vivo studies.
- Analysis of studies investigating resveratrol's effects on cell proliferation and immune responses in ocular models.
- Examination of research focusing on the anti-carcinogenic properties of resveratrol and their relevance to retinal diseases.
Main Results:
- Resveratrol demonstrates a wide range of potential therapeutic effects in ophthalmological studies.
- Observed effects include significant antiproliferative and immune modulatory actions without apparent toxicity.
- The nuclear factor-kappa B (NF-κB) pathway is identified as a primary target of resveratrol.
Conclusions:
- Resveratrol shows considerable promise for treating eye fundus diseases based on in vitro and in vivo evidence.
- Further clinical trials are essential to validate these findings and establish resveratrol's efficacy in human patients.
- The precise molecular mechanisms underlying resveratrol's effects require further elucidation, as they appear to be context-dependent.
